Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Ann Neurol. 2015 Oct 31;78(6):860–870. doi: 10.1002/ana.24510

Table 1.

Patients’ Demographic and Clinical Characteristics

Cohort 1
(N=37)
Cohort 2
(N=39)
Combined
(N=76)
Demographic
Age (yrs) 60.7 (16.4) 56.9 (11.2) 58.8 (14.0)
Male (%) 64.9% 56.4% 60.5%
Ethnicity
    Caucasian 81.1% 64.1% 72.4%
  African American 8.1% 35.9% 22.4%
    Others 10.8% 0% 5.3%
Education (College or higher) 47.2% 13.6% 30.1%
Lesion side (Right) 62.1% 69.2% 65.4%
Right Handed 91.9% 97.4% 96.1%
tPA or Reperfusion Therapy 37.8% 26.8% 31.6%
Stroke subtype
Small vessel disease 18.9% 28.2% 23.7%
Cardioembolism 32.4% 18.0% 25.0%
Large vessel atherosclerotic disease 18.9% 33.3% 26.3%
Other or unknown etiology 29.7% 20.5% 25.0%
Disposition
Length of stay (days) 5.8 (3.3) 6.6 (6.0) 6.2 (4.9)
Days between onset of stroke symptom and the first assessment 2.9 (1.5) 2.0 (1.2) 2.4 (1.5)
Days between stroke admission and follow up 92.6 (14.4) 94.3 (10.5) 93.5(13.4)
Days of rehabilitation therapy 39.8 (18.8) 29.8 (17.5) 34.5 (18.7)
Acute rehabilitation facility (%) 91.9% 71.8% 81.6%
Behavioral Assessment
NIHSS at baseline 9.2 (6.4) 8.7 (5.2) 9.0 (5.8)
NIHSS at 3 months 4.4 (5.1) 3.9 (3.5) 4.2 (4.3)
UE-FM at baseline 24.8 (19.7) 25.1 (19.6) 25.0 (19.5)
UE-FM at 3 months 42.5 (23.8) 42.3 (23.3) 42.4 (23.4)
mRS 2.3 (1.5) 2.5 (1.3) 2.4 (1.4)
Imaging Information
wCST-LL 4.16 (3.06) 3.74 (3.21) 394 (3.12)
Lesion Volume 43.33 (59.78) 42.90(49.95) 43.11(54.58)
Outcome Prediction (R2)
Clinical assessment (initial motor impairment) 0.67 0.62 0.64
Imaging assessment (wCST-LL) 0.69 0.69 0.69